Corient Private Wealth
OSCR icon

Corient Private Wealth’s Oscar Health OSCR Stock Holding History

Corient Private Wealth’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Sell
18,589
-95,563
-84% -$2.06M ﹤0.01% 2177
2026
Q1 		$1.3M Buy
+114,152
New +$1.61M ﹤0.01% 1491
2024
Q4 		– Sell
-22,741
Closed -$482K – 2481
2024
Q3 		$482K Buy
22,741
+7,600
+50% +$137K ﹤0.01% 1749
2024
Q2 		$240K Buy
15,141
+276
+2% +$5.07K ﹤0.01% 2027
2024
Q1 		$221K Sell
14,865
-10
-0.1% -$137 ﹤0.01% 2054
2023
Q4 		$136K Hold
14,875
– – ﹤0.01% 2122
2023
Q3 		$82.9K Sell
14,875
-59
-0.4% -$413 ﹤0.01% 2047
2023
Q2 		$120K Sell
14,934
-77
-0.5% -$568 ﹤0.01% 1950
2023
Q1 		$98.2K Sell
15,011
-442
-3% -$1.8K ﹤0.01% 1887
2022
Q4 		$38K Buy
+15,453
New +$48.3K ﹤0.01% 1645

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corient Private Wealth's OSCR Position: Q2 2026 in Review

Corient Private Wealth reduced its Oscar Health (OSCR) stake by 84% in Q2 2026, selling an estimated $2.06M and leaving 18,589 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

Corient Private Wealth first reported a position in OSCR in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.3M in Q1 2026. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Corient Private Wealth held 18,589 shares of Oscar Health worth $530K as of Q2 2026.
  • Corient Private Wealth sold 95,563 Oscar Health shares in Q2 2026, an estimated $2.06M.
  • Oscar Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2177 holding.
  • Corient Private Wealth first reported a position in Oscar Health in Q4 2022 and has held it in 10 quarters since.
  • Corient Private Wealth's Oscar Health position peaked at $1.3M in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.